This week, we will be discussing a very important topic, of which a lot of people have never heard while others have only rudimentary knowledge about the condition.
In the phase 2 NICHE-3 trial, patients with locally advanced mismatch repair-deficient colon cancer who were treated with neoadjuvant anti-PD1 and anti-LAG3 agents showed high rates of ...
(NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) as an add-on maintenance treatment for adolescent patients aged ...
CRSwNP is a chronic disease of the upper airway, driven in part by type 2 inflammation ... uncontrolled symptoms and the recurrence of nasal polyps. In the U.S., approximately 9,000 adolescents ...
inflammation, and adenomas. While polyps are primarily classified according to their site of occurrence, including nasal polyps, gallbladder polyps, colon polyps, and gastric polyps, among others, ...
Shai Bel and his research team at the Azrieli Faculty of Medicine of Bar-Ilan University have uncovered crucial insights into how antibiotic use increases the risk of inflammatory bowel disease (IBD).